Literature DB >> 1649041

Hepatocellular carcinoma. A worldwide problem and the major risk factors.

R G Simonetti1, C Cammà, F Fiorello, F Politi, G D'Amico, L Pagliaro.   

Abstract

Male sex, age, cirrhosis, and HBsAg are the major risk factors for hepatocellular carcinoma (HCC). The geographic distribution of HCC is highly uneven, such that three distinct incidence areas are recognized. To clarify the reason(s) for this geographic variability of HCC, the risk factors in each incidence area were assessed. In parallel with the geographic distribution of HCC, HBsAg prevalence was highest in both HCC patients and in general population in Africa and Asia, where mothers of HCC patients are frequently HBsAg-positive, suggesting that hepatitis B virus hyperendemicity and perinatal infection account for the high HCC incidence in these areas. Cirrhosis, which is found on autopsy in 80% of the cases of HCC patients worldwide, is the most prevalent risk factor for HCC in areas where hepatitis B virus infection is less common. However, HBsAg carriage adds to the HCC risk carried by cirrhosis and explains the higher incidence of HCC in cirrhotics from Africa and Asia as well as elsewhere. Available data suggest that chronic HCV infection is a risk factor for cirrhosis and HCC. HBV vaccination should decrease HCC incidence rates worldwide; however, HCC prevention in regions where HBsAg carriage is infrequent may also require prevention of the other causes of cirrhosis in order for HCC rates to decline.

Entities:  

Mesh:

Year:  1991        PMID: 1649041     DOI: 10.1007/bf01297149

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  97 in total

1.  [Primary cancer of the liver in France; 25 cases].

Authors:  J P BENHAMOU; R FAUVERT
Journal:  Sem Hop       Date:  1958-01-20

2.  [Incidence and form of primary cancer of the liver].

Authors:  J ZEITLHOFER
Journal:  Krebsarzt       Date:  1951-06-01

3.  Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis.

Authors:  P J Johnson; N Krasner; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

4.  Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma.

Authors:  L I Lutwick
Journal:  Lancet       Date:  1979-04-07       Impact factor: 79.321

5.  Hepatitis B viral markers in patients with chronic hepatitis and with primary hepatocellular carcinoma in Taiwan.

Authors:  M J Tong; M C Chien; K J Lo; Y T Tsai; J K Lee
Journal:  Prog Med Virol       Date:  1981

Review 6.  Hepatocellular carcinoma and type B hepatitis.

Authors:  S J Hadziyannis
Journal:  Clin Gastroenterol       Date:  1980-01

7.  Hepatocellular carcinoma in Chinese males and females. Possible causes for the male predominance.

Authors:  C L Lai; P B Gregory; P C Wu; A S Lok; K P Wong; M M Ng
Journal:  Cancer       Date:  1987-09-01       Impact factor: 6.860

8.  Hepatocellular carcinoma in alcoholic liver disease: no evidence for a pathogenetic role of hepatitis B virus infection.

Authors:  E Walter; H E Blum; P Meier; M Huonker; M Schmid; K P Maier; W B Offensperger; S Offensperger; W Gerok
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

9.  Hepatitis B surface antigen produced by a human hepatoma cell line.

Authors:  G M MacNab; J J Alexander; G Lecatsas; E M Bey; J M Urbanowicz
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

10.  Sex steroid receptor proteins in foetal, adult and malignant human liver tissue.

Authors:  M J Iqbal; M L Wilkinson; P J Johnson; R Williams
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640

View more
  102 in total

1.  Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patients.

Authors:  Mitsuhiro Takimoto; Shogo Ohkoshi; Takafumi Ichida; Yasuo Takeda; Minoru Nomoto; Hitoshi Asakura; Akira Naito; Shigeki Mori; Kojiro Hata; Kentaro Igarashi; Hidenori Hara; Hironobu Ohta; Kenji Soga; Toshiaki Watanabe; Tomoteru Kamimura
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

2.  Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study.

Authors:  Pin-Gao Yan; Ruo-Yu Wang; Jin Zhang; Wen-Ming Cong; Hui Dong; Hong-Yu Yu; Wan Yee Lau; Meng-Chao Wu; Wei-Ping Zhou
Journal:  J Gastrointest Surg       Date:  2018-01-08       Impact factor: 3.452

3.  Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients.

Authors:  Linda-L Wong; Whitney-M Limm; Naoky Tsai; Richard Severino
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

4.  Baseline characterization of patients aged 70 years and above with hepatocellular carcinoma.

Authors:  Makoto Nakamuta; Shusuke Morizono; Motoyuki Kohjima; Kazuhiro Kotoh; Munechika Enjoji
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

5.  Epidemiology and carcinogenesis of hepatocellular carcinoma.

Authors:  Trishe Y-M Leong; Anthony S-Y Leong
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

6.  A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.

Authors:  Mei Liu; Xinxin Liu; Pengfei Ren; Jitian Li; Yurong Chai; Su-Jun Zheng; Yu Chen; Zhong-Ping Duan; Ning Li; Jian-Ying Zhang
Journal:  Tumour Biol       Date:  2014-01-04

7.  In vivo assessment of angioarchitecture and microcirculation in experimental liver cancer: a new model in rats.

Authors:  S M Maksan; H Paulo; E Ryschich; C Kuntz; M M Gebhard; E Klar; J Schmidt
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

Review 8.  Advances in managing hepatocellular carcinoma.

Authors:  Marielle Reataza; David K Imagawa
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

Review 9.  Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.

Authors:  Cristina Della Corte; Alessio Aghemo; Massimo Colombo
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

10.  Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis.

Authors:  T Chiba; Y Matsuzaki; M Abei; J Shoda; T Aikawa; N Tanaka; T Osuga
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.